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Abstract We previously demonstrated the functional coupling
of the rat neurotensin receptor NTS1 with G-proteins on
transfected CHO cell homogenates by showing modulation of
agonist affinity by guanylyl nucleotides and agonist-mediated
stimulation of [35S]GTPQS binding. In the present study, we
observed that Gi=o-type G-protein inactivation by pertussis toxin
(PTx) resulted in a dramatic reduction of the NT-induced
[35S]GTPQS binding whereas the effect of guanylyl nucleotide
was almost not affected. As expected, NT-mediated phospho-
inositide hydrolysis and intracellular calcium mobilization were
not altered after PTx treatment. This suggests the existence of
multiple signaling cascades activated by NT. Accordingly, using
PTx and the PLC inhibitor U-73122, we showed that both
signaling pathways contribute to the NT-mediated production of
arachidonic acid. These results support evidence for a dual
coupling of the NTS1 with PTx-sensitive and insensitive
G-proteins. ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The e¡ects of the neuropeptide neurotensin (NT) are
thought to result from its high a⁄nity interaction with speci¢c
membrane receptors. Early binding studies conducted on
brain tissues and cell lines led many authors to propose the
existence of multiple NT binding sites. Three NT receptor
subtypes have now been cloned and named: high a⁄nity neu-
rotensin receptor (NTS1), nts2 and nts3. NTS1 and nts2 be-
long to the large family of G-protein-coupled receptors [1,2]
whereas nts3 corresponds to the previously characterized
gp95/sortilin containing a single transmembrane domain [3]
(for review, see [4]). In contrast to nts2 and nts3, that were
only clearly identi¢ed in the late 1990s, NTS1 has received
much more attention and was extensively studied in a large
variety of cell lines, tissues and recombinant systems for more
than a decade. The coupling of this receptor with G-proteins
is demonstrated by the ability of guanylyl nucleotides and
Na ions to modulate the binding a⁄nity of NT agonists
[5^7]. Although both positive and negative controls of adenyl-
yl cyclase by NT were reported in some cultured cells express-
ing NTS1 [5,8], most of the e¡ects of NT have been attributed
to the activation of PLC (for review, see [4,9]). This suggests
the involvement of Gq=11-type G-proteins and accordingly,
many responses to NT are una¡ected by the inactivation of
Gi=o-type G-proteins by pertussis toxin (PTx) or N-ethylma-
leimide [10^13]. However, this is not the rule and a number of
authors have also proposed a possible coupling of NT recep-
tors with other signaling pathways that are proposed to in-
volve PTx-sensitive G-proteins [12,14^17].
Using transfected Chinese hamster ovary (CHO) cells ex-
pressing NTS1 (CHO-NTR), we have previously reported on
the NT-induced accumulation of inositol phosphates (InsP)
[10], production of arachidonic acid [18], mobilization of in-
tracellular calcium [19] and increase in [35S]GTPQS binding
[20]. On the basis of further biochemical analysis, we now
provide evidence that these functional responses are depen-
dent on the dual coupling of the receptor with both PTx-
sensitive and insensitive G-proteins. In addition, selective in-
hibition of these signaling pathways revealed that both cou-
plings contribute to the NT-induced production of arachidon-
ic acid.
2. Materials and methods
2.1. Materials
Fura-2 AM was obtained from Molecular Probes, guanosine-5P-O-
(3-[35S]thio)triphosphate ([35S]GTPQS) (speci¢c activity 1000 Ci/mmol)
[3H]arachidonic acid (100 Ci/mmol) and [3H]NT (101 Ci/mmol) were
from NEN-Dupont, myo-[2-3H]inositol (70^120 Ci/mmol) from
Amersham. PTx, NT, ionomycin, dithiothreitol, 1,10-phenanthroline,
GDP, 5P-guanylylimidodiphosphate (Gpp(NH)p) and polyethyleni-
mine were from Sigma Chemical Co, compound U-73122 was from
RBI. Glass ¢ber ¢lters were from Whatman and Brandel.
2.2. Cell culture
Transfected CHO cells expressing the rat NTS1 [10] were grown in
MEM alpha medium supplemented with 10% fetal calf serum,
85 Wg/ml streptomycin and 85 U/ml penicillin. Cultures were main-
tained at 37‡C in a humidi¢ed atmosphere of 5% CO2^95% air. For
[Ca2]i, measurements, cells were cultured on glass coverslips. When
indicated, 100 ng/ml PTx was added in the culture medium 20 h
before use.
2.3. Binding of [35S]GTPQS and [3H]NT
The speci¢c binding of [35S]GTPQS and [3H]NT were measured on
cell homogenates as previously described [20]. Brie£y, cell homoge-
nates (25^50 Wg) were resuspended in binding bu¡er (50 mM Tris^
HCl pH 7.4 containing 5 mM MgCl2, 1 WM 1,10-phenanthroline,
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0.1% BSA). For [35S]GTPQS binding studies, this bu¡er was supple-
mented with 1 WM GDP, 150 mM NaCl and 1 mM dithiothreitol. The
homogenate was incubated for 30 min in the presence of either 0.05
nM [35S]GTPQS or 0.5 nM [3H]NT at 37 or 30‡C, respectively. The
non-speci¢c binding of [35S]GTPQS and [3H]NT were measured in the
presence of 0.1 mM Gpp(NH)p or 0.1 WM NT, respectively. Incuba-
tion was terminated by addition of 3 ml ice-cold binding bu¡er and
the suspension was immediately ¢ltered through GF/B glass ¢ber
¢lters (pre-soaked for 1 h in 0.5% polyethylenimine for [3H]NT bind-
ing experiments) and washed twice with the same bu¡er using a 24
channels Brandel Harvester (Semat). Radioactivity trapped on the
¢lter was estimated by scintillation counting. All the binding data
were analyzed by non-linear regression using the software GraphPad
Prism, version 2.00.
2.4. Measurement of [3H]InsP
For assessment of [3H]InsP, cells grown in 24 multiwell plates were
labeled with 1 WCi/ml, myo-[2-3H]inositol for 48 h in culture medium.
Thereafter, cells were washed three times with 0.5 ml of Ham-F12
medium supplemented with 10 mM LiCl and 0.1% BSA and 1 WM
1,10-phenanthroline, and incubated in this bu¡er for 15 min before
the addition of the NT. Experiments were performed at 37‡C in a ¢nal
volume of 0.5 ml/well and were terminated by the addition of 0.5 ml
ice-cold 1 M trichloroacetic acid. After extraction on ice for 20 min,
samples (0.8 ml) were collected from the well, mixed with 200 Wl
EDTA (10 mM, pH 7.0) and extracted with 1 ml of a 1:1 (v/v)
mixture of tri-n-octylamine and 1,1,2-trichlorotri£uoroethane. An
800 Wl sample of the aqueous extract was mixed with 50 Wl NaHCO3
(62.5 mM) and the [3H]InsP fraction was recovered by ion-exchange
chromatography as previously described [21].
2.5. [Ca2+]i measurements
Cells were loaded with 5 WM Fura-2 AM for 60 min at room
temperature. Rinsed coverslips were then mounted in a thermostatized
(20‡C) and perfused microscope chamber (1 ml). Fura-2-loaded cells
were excited alternatively at 340 and 380 nm and £uorescence emis-
sion was monitored at 510 nm using a Deltascan spectro£uorimeter
(Photon Technology international) coupled to an inverted microscope
(Nikon Diaphot, oil immersion objective 100U N.A. 1.3). Fluores-
cence intensities from single cells excited at the two wavelengths were
recorded and [Ca2]i was estimated using an intracellular calibration
procedure, after cell permeabilization with 5 WM ionomycin at the end
of the experiment [22].
2.6. Measurement of arachidonic acid release
Cells grown in 6-well dishes were incubated with 0.5 pCi/well
[3H]arachidonic acid for 24 h at 37‡C allowing a progressive incorpo-
ration of labeled arachidonic acid into membrane phospholipids.
After washing, the cells were stimulated with NT for 5 min in Krebs
bu¡er medium containing fatty acid free BSA (0.2%) and
[3H]arachidonic acid released in the medium was quanti¢ed by liquid
scintillation counting [18].
3. Results
3.1. Functional coupling with G-proteins
The functional coupling of the NTS1 expressed in CHO-
NTR cells was evaluated by measuring the ability of NT to
induce [35S]GTPQS binding and by the ability of Gpp(NH)p to
decrease the speci¢c binding of [3H]NT to cell homogenates.
As previously described, in the presence of GDP (1 WM), NT
was found to considerably enhance (150% above basal) the
speci¢c binding of [35S]GTPQS on CHO-NTR homogenates
(Fig. 1A). The relative low potency of NT found in these
experiments is a consequence of the high concentration of
NaCl (150 mM) required in this functional assay that de-
creases the a⁄nity of NT for its receptor. On cells previously
treated with PTx, the functional response to NT was dramat-
ically reduced (maximal 13% increase in nucleotide binding
above basal). However, the potency of NT was not a¡ected
(pEC50 values of 7.98 þ 0.12 and 7.93 þ 0.14 on homogenates
from control and PTx-treated cells, respectively). The e¡ect of
PTx treatment on the interaction of the NTS1 with G-protein
was further investigated by measuring the e¡ects of
Gpp(NH)p and NaCl on the binding of [3H]NT. Pretreating
the cells with PTx resulted in a signi¢cant decrease in the
speci¢c binding of (0.5 nM) [3H]NT measured on cell homo-
genates. However, on both control and PTx-treated cells,
Gpp(NH)p was found to decrease the speci¢c binding of
[3H]NT in a similar extent and with a similar potency
(pEC50 values of 6.95 þ 0.12 and 7.13 þ 0.17 on homogenates
from control and PTx-treated cells, respectively). Addition of
NaCl (150 mM) in the assay also decreased the speci¢c bind-
ing of [3H]NT. As usually reported [7,23], the e¡ect of Na
and Gpp(NH)p were additive and after their co-application,
the binding of [3H]NT was almost undetectable. Pretreatment
of the cells with PTx did not prevent the e¡ect of NaCl on the
binding of [3H]NT.
3.2. NT-induced [3H]InsP production and [Ca2+]i
mobilization
We previously showed that NTS1 expressed in transfected
CHO cells is functionally coupled to PLC [10]. The G-proteins
involved in this coupling were studied by measuring the e¡ect
of PTx treatment on NT-induced phosphoinositide hydrolysis,
Fig. 1. (A) NT-induced [35S]GTPQS binding on homogenates from
CHO-NTR cells previously treated in the presence (closed symbols)
or in the absence (open symbols) of PTx (100 Wg/ml, 20 h). (B) Ef-
fect of Gpp(NH)p (increasing concentrations) and NaCl (control,
circles; 150 mM NaCl, triangles) on the speci¢c binding of [3H]NT
to homogenates from CHO-NTR cells previously treated in the
presence (closed symbols) in the absence (open symbols) of PTx
(100 Wg/ml, 20 h). Data shown are mean þ S.D. from ¢ve (A) and
three (B) di¡erent experiments performed in duplicate, respectively.
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evaluated by the accumulation of [3H]InsP (measured after 30
min stimulation with NT in the presence of LiCl). NT induced
a nearly fourfold increase in [3H]InsP accumulation with a
potency in accordance with its a⁄nity for the NTS1 receptor
[24] (pEC50 value of 8.89 þ 0.23, n = 5), (Fig. 2A). Neither the
e⁄cacy, nor the potency of NT were a¡ected by PTx treat-
ment (pEC50 value of 9.16 þ 0.17, n = 5).
CHO-NTR cells respond to NT stimulation with a large
release of Ca2 from the endoplasmic reticulum followed by
sustained entry of Ca2 from the extracellular space [19]. This
response is triggered by InsP3 as shown by its sensitivity to
micro-injected heparin [22]. In the present study, we focused
our attention on the initial phase which is better characterized
in the absence of extracellular calcium (0.2 mM EGTA). This
response was maximal at a concentration of 1 nM NT, con-
sisting in a [Ca2]i transient that reached about 1WM and
faded away in about 1 min (Fig. 2B). The [Ca2]i transient
induced by 10 nM NT was not a¡ected by PTx treatment
indicating that the initial response to NT was not dependent
on the coupling of the receptor with PTx-sensitive G-protein.
Accordingly, complete inhibition was obtained by addition
(15 min prior NT) of 5 WM U-73122, an inhibitor of PLC,
whose activation is proposed to mainly involve PTx-insensi-
tive G-protein. At 1 WM, this e¡ect was only partial (peak
reaching 180 nM, data not shown), in agreement with the
micromolar potency of this compound reported in the litera-
ture [8,25].
3.3. NT-induced [3H]arachidonic acid release
NTS1 was also found to be coupled to the activation of
PLA2 [18,26] and such coupling was shown to partially de-
pend on Ca2 mobilized from the reticulum. Fig. 3 shows that
NT-induced arachidonic acid production was decreased after
PTx treatment (53% of inhibition). In addition, partial inhi-
bition (52%) of this response was also obtained in the presence
of 5 WM U-73122 (added 15 min prior NT). These e¡ects were
additive, suggesting that NT-induced production of arachi-
donic acid involves both a PTx-sensitive G-protein and a
PLC-related PTx-insensitive pathway.
4. Discussion
In the vast majority of cellular and tissular models where
NTS1 has been studied, NT-mediated hydrolysis of phosphoi-
nositides and mobilization of Ca2 have been observed. Ac-
cordingly, stimulation of NTS1 is uniformly proposed to ac-
tivate PLC through a preferential coupling with Gq=11-type
G-proteins. In a previous work performed on CHO-NTR
cells, NT was shown to activate G-proteins, as revealed by
a robust increase in the speci¢c binding of [35S]GTPQS binding
[20]. The detection of nucleotide exchange induced by NT was
considered to reveal this predominant functional coupling.
However, an extensive review of the recent specialized litera-
ture indicates that unless sophisticated approaches involving
immunoprecipitation of G-proteins are used, the analysis of
[35S]GTPQS binding (on cell homogenates or by autoradiog-
raphy) is almost only applicable to receptors coupled to Gi=o-
type G-proteins [27^30]. On the basis of our previous studies
on the activation of PLC and PLA2 by NT [10,18], these
considerations prompted us to investigate the nature of the
G-proteins speci¢cally activated by NT in CHO-NTR cells. In
this purpose, discrimination between Gq=11- and Gi=o-type
G-proteins was performed by measuring the e¡ect of PTx
treatment on the NT signaling at both G-protein and e¡ector
levels.
Fig. 2. (A) NT-induced [3H]InsP accumulation in CHO-NTR cells
previously treated in the presence (closed symbols) or in the absence
(open symbols) of PTx. Data shown are mean þ S.D. from ¢ve dif-
ferent experiments performed in triplicate. (B) E¡ect of PTx (100
Wg/ml, 20 h) and U-73122 (5 WM, 15 min) on the NT (10 nM)-in-
duced [Ca2]i mobilization in single CHO-NTR cells in the absence
of extracellular Ca2. Control cells, solid line; PTx treated cells,
dotted line; U-73122 treated cells, dashed line. Data shown are rep-
resentative of at least ¢ve determinations.
Fig. 3. E¡ect of PTx (100 Wg/ml, 20 h) and U-73122 (5 WM, 15 min)
on the NT (10 nM)-induced arachidonic acid production. Data
shown are mean þ S.D. from 9 to 19 di¡erent determinations per-
formed in duplicate. *P6 0.05 as compared to control; #P6 0.05 as
compared to either PTx or U-73122 alone (ANOVA followed by Stu-
dent-Newman-Keuls test).
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The key ¢nding of the present study is the evidence for the
simultaneous coupling of NTS1 with both PTx-sensitive and
insensitive G-proteins. Thus, the nucleotide exchange induced
by NT was almost completely abolished on PTx-treated cells,
whereas as expected, such treatment was without e¡ect on the
activation of PLC. The weak detection of the coupling with
Gq=11-type G-proteins, inherent to this [35S]GTPQS binding
methods (see above), especially when simultaneous coupling
with another G-protein is observed, precludes any quantita-
tive comparison on the relative coupling to either PTx-sensi-
tive and insensitive signaling pathways. In addition, despite
the small amplitude of the response measured on PTx-treated
cells, analysis of NT-induced [35S]GTPQS binding revealed a
potency for NT that was almost identical to that found on
control cells. In both cases, the low potency of NT has to be
attributed to the relatively high concentration of NaCl re-
quired in this assay that dramatically decreases the a⁄nity
of agonists for the receptors [31]. Although some hypothesis
have been proposed to explain these di¡erences in the mea-
surements of nucleotide exchange at distinct G-proteins [32],
our attempts to enhance the NT-induced [35S]GTPQS binding
on PTx-treated cells (by changing the GDP or NaCl concen-
trations, the incubation time and the temperature) were not
conclusive.
In complement to [35S]GTPQS binding studies, the coupling
of the NTS1 with G-proteins was investigated by evaluating
the ability of the non-hydrolyzable guanylyl nucleotide
Gpp(NH)p to decrease the a⁄nity of NT for its receptor on
cell homogenates. Binding of agonists to both Gq=11- and
Gi=o-type G-proteins linked receptors are known to be e¡ec-
tively a¡ected by guanylyl nucleotides. Surprisingly, PTx
treatment did not a¡ect the coupling of NTS1 to G-proteins
in this indirect functional assay. Such discrepancy between the
results obtained using these two complementary approaches
suggests that although the coupling with Gi=o-type G-protein
is clearly demonstrated, the interaction with PTx-insensitive
G-proteins is predominant. The link between the ability of
Na ions to modulate the binding of agonist and the func-
tional coupling to G-proteins is still controversial for many
receptors [33]. However, in the case of NTS1, it was clearly
demonstrated that the mutation of a conserved aspartate res-
idue within the second transmembrane domain conferring this
Na ion sensitivity was a¡ecting the functional activation of
G-proteins [7]. In our hands, the e¡ect of Na ions was still
observed after PTx treatment. Based on these observations
and on the fact that the activation of PLC is also resistant
to PTx, one may propose that the modulation of NT binding
by both Na and Gpp(NH)p on CHO-NTR cells derives from
the predominant functional coupling with Gq=11-type G-pro-
tein.
NTS1 has been shown to induce arachidonic acid release
through the activation of PLA2 [18,26]. This activation was
shown to require calcium [18,34]. However contrasting with
the well established activation of PLC by GKq=11, the G-pro-
teins and intracellular pathways involved in PLA2 activation
seem more varied and/or controversial. Calcium directly acti-
vates the enzyme by binding to its amino-terminal C2 domain
(WM range), triggering its translocation from the cytosol to
the nuclear envelope and the reticulum [35^37]. An indirect
activation by calcium has also been shown, involving the cal-
cium-calmodulin dependent protein kinase II, the PKC and/or
the MAP kinase [18,34,38^40]. Finally, Gi-type G-proteins are
also implicated in the regulation of PLA2 [41] possibly
through the activation of MAP kinases by GKi2 [42], by the
LQ subunits released upon G-protein activation [43] or
through an in£ux of calcium [44]. In this study, both PTx
and the PLC inhibitor U-73122 decreased the arachidonic
acid production induced by NT. However, at a concentration
that completely inhibits [Ca2]i transients induced by NT
stimulation, U-73122 only decreased by half the amount of
arachidonic acid produced. Similarly, the inhibition was also
partial after a PTx treatment expected to maximally abolish
the Gi=o activation. The maximal e¡ects of U-73122 and PTx
treatments were additive suggesting that activation of PLA2
by NTS1 not only results from the ‘Gq-PLC ^ InsP3 ^ cal-
cium’ cascade but also from a direct coupling with Gi=o type
G-proteins.
Simultaneous coupling of membrane receptor with di¡erent
G-proteins has frequently been reported, especially when us-
ing recombinant models in which high levels of receptor ex-
pression may facilitate the detection of either promiscuous or
speci¢c but low-e⁄cient coupling. A variety of responses in-
duced by NT in vivo were shown to be dependent on GKi=o-
proteins and/or inhibited by PTx [15,17,25]. However, the
nature of the NT receptor subtype(s) expressed in these mod-
els was not identi¢ed. Moreover, in some of these studies, the
responses tested are those frequently proposed not to depend
on the activation of NTS1 (analgesia, hypothermia). In con-
trast, the present study provides a clear-cut evidence for an
independent functional coupling of the NTS1 to both PTx-
sensitive and PTx-insensitive G-proteins. Such functional cou-
pling of NTS1 with both GKq- and GKi1-proteins was ob-
served in a model of Escherichia coli expressing NTS1-GK
fusion proteins (R. Grisshammer and E. Hermans, unpub-
lished results). The existence of such multiple coupling is likely
to have physiological and pharmacological consequences,
leading to rather complex responses to agonists [45]. For in-
stance, it would be of interest to show whether the regulation
pro¢le of these distinct signaling pathways di¡er, as suggested
for other G-protein-coupled receptors [45].
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